VivoSeq
Other

Alcohol Withdrawal

24

Pipeline Programs↗

1

Active Trials↗

11

Companies Involved↗

Alcohol Withdrawal is an emerging landscape with 24 programs across 11 companies. The most active players are Viatris Specialty LLC, UCB, Novartis. 12 therapies are approved with 4 more in late-stage development.

Intelligence

Pipeline Metrics

Competitive Density

48/100

Pipeline Velocity

0/100

Mech. Concentration

15/100

Completion Rate

81/100

Attrition Rate

17/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

V

Viatris Specialty LLC

1 program

Phase 2UCB logo

UCB

1 program

Phase 3Novartis logo

Novartis

2 programs

ApprovedM

McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

2 programs

ApprovedF

Fresenius Kabi Oncology Ltd.

1 program

ApprovedR

Retrophin

1 program

Approved

Pipeline

Programs by Phase

Analysis

Trial Status

36

clinical trials

Completed25 · 69%
Unknown status4 · 11%
Terminated4 · 11%
Withdrawn2 · 6%
Enrolling by invitation1 · 3%

Clinical Trials

Trial Activity

36 trials

Safety & Efficacy of Baclofen for Alcohol Withdrawal in Chronic Liver Disease With Active Alcohol Consumption
Enrolling by invitation·CCorporacion Parc Tauli·N/A·NCT06840652·120 enrolled
Dexmedetomidine Addition to Benzodiazepines for Patients With Alcohol Withdrawal State in the ICU
Completed·—·Phase 4·NCT02496650·70 enrolled
Outpatient Treatment of Alcohol Withdrawal Syndrome
Completed·HHvidovre University Hospital·Phase 3·NCT00136617·165 enrolled
Magnesium After Alcohol Withdrawal Treatment
Completed·FFinnish Foundation for Alcohol Studies·Phase 4·NCT00325299·178 enrolled
Gabapentin for Alcohol Withdrawal Syndrome
Completed·MMayo Clinic·Phase 4·NCT03012815·88 enrolled
Gabapentin vs Chlordiazepoxide for Ambulatory Alcohol Withdrawal
Completed·VVA Salt Lake City Health Care System·Phase 4·NCT01573052·26 enrolled
MAGnesium Adjunction in Alcohol Withdrawal Syndrome: a Multicenter Assessment (MAGMA)
Completed·AAssistance Publique - Hôpitaux de Paris·Phase 3·NCT03033823·105 enrolled
Phenobarbital for Acute Alcohol Withdrawal
Completed·—·N/A·NCT01184417·102 enrolled
Comparing Gabapentin and Lorazepam for Treating Alcohol Withdrawal
Completed·National Institute on Alcohol Abuse and Alcoholism (NIAAA)·Phase 2·NCT00011297·160 enrolled
Remote Treatment of Alcohol Withdrawal
Completed·CCentre for Addiction and Mental Health·N/A·NCT04858490·30 enrolled
Intranasal Oxytocin Effects in Alcohol Withdrawal and Dependence; Follow-up Study
Completed·NNorwegian University of Science and Technology·Phase 3·NCT03339024·38 enrolled
Treating Alcohol Withdrawal With Oral Baclofen
Completed·EEssentia Health·N/A·NCT00597701·79 enrolled
A Comparison of Lorazepam and Diazepam in the Treatment of Alcohol Withdrawal
Completed·SStanford University·N/A·NCT00523185·55 enrolled
Antiglutamate Anticonvulsants in the Treatment of Alcohol Withdrawal Syndrome
Completed·SSt. Petersburg State Pavlov Medical University·N/A·NCT00241995
Dexmedetomidine as Adjunctive Therapy for Alcohol Withdrawal
Completed·UUniversity of Colorado, Denver·N/A·NCT00936377·24 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)